WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies - 08/10/20
Doi : 10.1016/j.neurol.2020.08.001
M. Etemadifar a, b, A. Aghababaee b, N. Sedaghat b, ⁎ 
, M. Rayani b, H. Nouri b, A. Abhari b, M. Salari c, N. Majdinasab d, M. Ghiasian e, A. Bayati f, S.M. Nabavi g, A. Mansouri h
, M. Rayani b, H. Nouri b, A. Abhari b, M. Salari c, N. Majdinasab d, M. Ghiasian e, A. Bayati f, S.M. Nabavi g, A. Mansouri h a Department of neurosurgery, Isfahan university of medical sciences, Isfahan, Iran
b Alzahra research institute, Isfahan university of medical sciences, Isfahan, Iran
c Department of neurological diseases, Shaid Beheshti university of medical sciences, Tehran, Iran
d Department of neurology, Ahvaz Jundishapur university of medical sciences, Ahvaz, Iran
e Department of neurology, Hamadan university of medical sciences, Hamadan, Iran
f Shahrekord university of medical sciences, Shahrekord, Iran
g Department of neurology and neuroregenerative, Royan institute, Tehran, Iran
h Hypertension research center, cardiovascular research institute, Isfahan university of medical sciences, Isfahan, Iran
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 08 October 2020
Résumé |
This article has been withdrawn at the request of the authors and editor. The Publisher apologizes for any inconvenience this may cause.
The full Elsevier Policy on Article Withdrawal can be found at article-withdrawal.
Le texte complet de cet article est disponible en PDF.© 2020
Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.